Ketojenik Diyetin Endikasyonları ve Kontrendikasyonları

Yazarlar

Pakize Karaoğlu

Özet

Ketojenik diyet, uygun seçilmiş ve tolere edilen en az iki antiepileptik ilaca rağmen nöbet kontrolü sağlanamayan dirençli epilepsi hastalarında ve Ohtahara, West, Lennox-Gastaut, Dravet ile Doose sendromları gibi çeşitli epileptik ensefalopatilerde etkili bir tedavi seçeneğidir. Bunun yanı sıra, beynin enerji metabolizmasındaki glukoz transporter protein 1 (GLUT-1) eksikliği sendromu ve pirüvat dehidrogenaz eksikliğinde beyne alternatif bir yakıt kaynağı olan ketonları sağlayarak ilk seçenek tedavi olarak kullanılır. Ayrıca infantil spazm, tüberoskleroz kompleksi, FIRES, süper refrakter status epileptikus, Angelman sendromu ve gastrostomi ile beslanan hastalar gibi birçok spesifik nörolojik ve metabolik durumda fayda sağladığı bildirilmiştir. Ancak, karbonhidrat yerine lipidlerin birincil enerji kaynağına dönüştüğü metabolik adaptasyon nedeniyle yağ asidi transport ve oksidasyon bozuklukları (karnitin eksikliği, CPT I ve II eksiklikleri, MCAD, LCAD vb.), pirüvat karboksilaz eksikliği ve porfiri durumlarında kesin olarak kontrendikedir. Yetersiz beslenmeyi sürdürememe, hasta veya bakımveren uyumsuzluğu, eş zamanlı propofol kullanımı ve cerrahi rezeksiyona uygun fokal odakların bulunması ise rölatif kontrendikasyonlar arasında yer almaktadır. Bu nedenle diyete başlanmadan önce olası katabolik krizleri ve ciddi komplikasyonları önlemek amacıyla yağ metabolizması bozuklukları yönünden dikkatli bir tarama yapılması gerekmektedir.

Referanslar

Kwan P, Brodie MJ. Effectiveness of first antiepileptic drug. Epilepsia 2001; 42:1255.

Kwan P, Arzimanoglou A, Berg AT, et al. Definition of Drug Resistant Epilepsy: Consensus Proposal by the Ad Hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 2010;51:1069-1077.

Luat AF, Coyle L, Kamat D. The Ketogenic Diet: A Practical Guide for Pediatricians. Pediatr Ann 2016;45(12):e446-e450.

Freeman JM, Vining EP, Kossoff EH, et al. A blinded, crossover study of the efficacy of the ketogenic diet. Epilepsia 2009;50:322-325.

Sharma S, Tripathi M. Ketogenic diet in epileptic encephalopathies. Epilepsy Res Treat 2013;2013:652052.

Kass HR, Winesett SP, Bessone SK, et al. Use of dietary therapies amongst patients with GLUT1 deficiency syndrome. Seizure 2016; 35:83.

Sofou K, Dahlin M, Hallböök T, et al. Ketogenic diet in pyruvate dehydrogenase complex deficiency: short- and long-term outcomes. J Inherit Metab Dis 2017;40:237-245.

Dressler A, Trimmel-Schwahofer P, Reithofer E, et al. The ketogenic diet in infants-Advantages of early use. Epilepsy Res 2015;116:53-58.

Kim JA, Yoon JR, Lee EJ, et al. Efficacy of the classic ketogenic and the modified Atkins diets in refractory childhood epilepsy. Epilepsia 2016;57:51-58.

van der Louw E, van den Hurk D, Neal E, et al. Ketogenic diet guidelines for infants with refractory epilepsy. Eur J Paediatr Neurol 2016;20:798-809

Cervenka MC, Henry BJ, Felton EA, et al. Establishing an Adult Epilepsy Diet Center: experience, efficacy and challenges. Epilepsy Behav 2016;58:61–68.

Kossoff EH, Zupec-Kania BA, Auvin S,et al; Charlie Foundation; Matthew's Friends; Practice Committee of the Child Neurology Society. Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the International Ketogenic Diet Study Group. Epilepsia Open 2018;3(2):175-192.

Pascual JM, Liu P, Mao D, et al. Triheptanoin for glucose transporter type I deficiency (G1D): modulation of human ictogenesis, cerebral metabolic rate, and cognitive indices by a food supplement. JAMA Neurol 2014; 71:1255.

Kang HC, Lee YM, Kim HD, et al. Safe and effective use of the ketogenic diet in children with epilepsy and mitochondrial respiratory chain complex defects. Epilepsia 2007;48:82-88.

Caraballo RH, Cersósimo RO, Sakr D, et al. Ketogenic diet in patients with myoclonic-astatic epilepsy. Epileptic Disord 2006; 8:151.

Mullen SA, Marini C, Suls A, et al. Glucose transporter 1 deficiency as a treatable cause of myoclonic astatic epilepsy. Arch Neurol 2011; 68:1152.

Dressler A, Trimmel-Schwahofer P, Reithofer E, et al. Efficacy and tolerability of the ketogenic diet in Dravet syndrome-Comparison with various standard antiepileptic drug regimen. Epilepsy Res 2015;109:81-89.

Park S, Lee EJ, Eom S, et al. Ketogenic Diet for the Management of Epilepsy Associated with Tuberous Sclerosis Complex in Children. J Epilepsy Res 2017;7(1):45-49.

Prezioso G, Carlone G, Zaccara G, et al. Efficacy of ketogenic diet for infantile spasms: A systematic review. Acta Neurol Scand 2018;137:4-11.

Sivaraju A, Nussbaum I, Cardoza CS, et al. Substantial and sustained seizure reduction with ketogenic diet in a patient with Ohtahara syndrome. Epilepsy Behav Case Rep 2015;3:43-45.

Millichap JJ, Millichap JG. Ketogenic diet as preferred treatment of FIRES. Pediatr Neurol Briefs 2015;29:3.

Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in school age children (FIRES). Epilepsia 2010;51:2033–2037.

Appavu B, Vanatta L, Condie J, et al. Ketogenic diet treatment for pediatric super-refractory status epilepticus. Seizure 2016;41:62-65.

Hosain SA, La Vega-Talbott M, Solomon GE. Ketogenic diet in pediatric epilepsy patients with gastrostomy feeding. Pediatr Neurol 2005;32:81-83.

Grocott OR, Herrington KS, Pfeifer HH, et al. Low glycemic index ttreatment for seizure control in Angelman syndrome: A case series from the Center for Dietary Therapy of Epilepsy at the Massachusetts General Hospital. Epilepsy Behav 2017;68:45-50.

Jurecka A, Opoka-Winiarska V, Rokicki D, et al. Neurologic presentation, diagnostics, and therapeutic insights in a severe case of adenylosuccinate lyase deficiency. J Child Neurol 2012;27:645–649.

Lim Z, Wong K, Olson HE, et al. Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients. Epilepsia 2017;58:1415–1422.

Groomes LB, Pyzik PL, Turner Z, et al. Do patients with absence epilepsy respond to ketogenic diets? J Child Neurol 2011;26:160–165.

Swoboda KJ, Specht L, Jones HR, et al. Infantile phosphofructokinase deficiency with arthrogryposis: clinical benefit of a ketogenic diet. J Pediatr 1997;131:932–934.

Busch V, Gempel K, Hack A, et al. Treatment of glycogenosis type V with ketogenic diet. Ann Neurol 2005;58:341

Kossoff EH, Henry BJ, Cervenka MC. Efficacy of dietary therapy for juvenile myoclonic epilepsy. Epilepsy Behav 2013;26:162-164.

Caraballo R, Noli D, Cachia P. Epilepsy of infancy with migrating focal seizures: three patients treated with the ketogenic diet. Epileptic Disord 2015;17:194-197.

Jung DE, Kang HC, Kim HD. Long-term outcome of the ketogenic diet for intractable childhood epilepsy with focal malformation of cortical development. Pediatrics 2008;122:e330-e333.

Cardinali S, Canafoglia L, Bertoli S, et al. A pilot study of a ketogenic diet in patients with Lafora body disease. Epilepsy Res 2006;69:129-134.

Bergqvist AG, Chee CM, Lutchka LM, et al. Treatment of acquired epileptic aphasia with the ketogenic diet. J Child Neurol 1999;14:696-701.

Lemmon ME, Terao NN, Ng YT, et al. Efficacy of the ketogenic diet in Lennox-Gastaut syndrome: a retrospective review of one institution’s experience and summary of the literature. Dev Med Child Neurol 2012;54:464-468.

Liebhaber GM, Riemann E, Baumeister FA. Ketogenic diet in Rett syndrome. J Child Neurol 2003;18:74–75.

Bautista RE. The use of the ketogenic diet in a patient with subacute sclerosing panencephalitis. Seizure 2003;12:175-177.

Kelley SA, Kossoff EH. How effective is the ketogenic diet for electrical status epilepticus of sleep? Epilepsy Res 2016;127:339-343.

Baumeister FA, Oberhoffer R, Liebhaber GM, Kunkel J, Eberhardt J, Holthausen H, Peters J. Fatal propofol infusion syndrome in association with ketogenic diet. Neuropediatrics 2004;35:250-252.

Stainman RS, Turner Z, Rubenstein JE, et al. Decreased relative efficacy of the ketogenic diet for children with surgically approachable epilepsy. Seizure 2007;16:615–619.

Stafstrom CE, Rho JM. The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol 2012;3:59.

van der Louw EJTM, Williams TJ, Henry-Barron BJ, et al. Ketogenic diet therapy for epilepsy during pregnancy: a case series. Seizure 2017;45:198–201.

Gelecek

30 Eylül 2021

Lisans

Lisans